Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS)
is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS further its mission by (1) developing psychedelics and marijuana into prescription medicines; (2) training therapists and working to establish a network of treatment centers; (3) supporting scientific research into spirituality, creativity, and neuroscience; and (4) educating the public honestly about the risks and benefits of psychedelics and marijuana. MAPS is now planning Phase 3 clinical trials of MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD), and anticipates U.S. Food and Drug Administration (FDA) approval of MDMA-assisted psychotherapy for PTSD as soon as 2021.
The Beckley Foundation
is a UK–based think tank and UN-accredited NGO founded by Amanda Feilding in 1998. We combine science and policy to further our understanding of consciousness and its altered states, and to effect changes in global drug policy in order to improve public health. We are at the forefront of scientific research into the potential medical benefits of psychedelics, cannabis and MDMA, and are pioneering in our contribution to international drug policy reform.
The Scientific Programme initiates, develops and supports scientific research through an international network of collaborative partnerships with leading scientists and institutions
. Studies focus on cannabis, psychedelics (psilocybin, LSD, ayahuasca, DMT), and MDMA. We investigate the action of these substances upon the human brain, using the latest developments in neuroscience and brain-imaging technology, and direct clinical trials. The research aims to increase our scientific understanding of consciousness, and to use this knowledge to treat mental and physical illness, expand awareness and enhance well-being and creativity.